Late diagnosis of rhinocerebral mucormycosis in patients with COVID-19 (case studies)
Description
From the beginning of the COVID-19 pandemic, the incidence of secondary infections (both bacterial and fungal) has increased due to immune suppression associated with the use of corticosteroids or broad-spectrum antibiotics as a part of COVID-19
